Preventive oncology focuses on strategies to reduce the incidence and impact of cancer through early detection, lifestyle modifications, and vaccination. Screening programs play a vital role in identifying precancerous lesions or early-stage cancers, enabling timely intervention and improved outcomes. Additionally, public health initiatives promote smoking cessation, healthy diet choices, regular exercise, and sun protection to mitigate cancer risk factors. Vaccinations against hepatitis B and human papillomavirus (HPV) target viruses linked to liver and cervical cancers, respectively, contributing to disease prevention. Furthermore, genetic counseling and testing help individuals understand their inherited cancer risks, empowering them to make informed decisions about surveillance and risk-reducing strategies. By integrating these approaches, preventive oncology strives to reduce the burden of cancer on individuals and communities.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States